HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the relationship between T663A polymorphism in the alpha-epithelial sodium channel gene and essential hypertension.

AbstractOBJECTIVES:
To evaluate the relationship between alpha epithelial sodium channel (alpha-ENaC) T663A polymorphism and the risk of essential hypertension
METHODS:
This meta-analysis was conducted between November 2014 and February 2015 in Shanghai Medical Instrumentation College, Shanghai, China. We collected all published available case-control data (N=12) identified through PubMed, Web of Science, Scopus, and Chinese National Knowledge Infrastructure (CNKI) up to December 2014. The pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using the fixed- or random-effect model. 
RESULTS:
  Although subgroup analysis showed that alpha-ENaC T663A polymorphism was associated with essential hypertension in North American individuals (OR=1.55, 95% CI=1.22-1.98, p=0.0003), our meta-analysis results did not confirm such association overall (OR=1.03, 95% CI=0.92-1.15, p=0.62). The lack of association was further confirmed by the non-superiority test (p less than 0.0001). 
CONCLUSION:
Alpha-ENaC T663A polymorphism might not be a risk factor for essential hypertension.
AuthorsWenchao Yang, Zhenmin Zhu, Jin Wang, Wei Ye, Yong Ding
JournalSaudi medical journal (Saudi Med J) Vol. 36 Issue 9 Pg. 1039-45 (Sep 2015) ISSN: 1658-3175 [Electronic] Saudi Arabia
PMID26318459 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Epithelial Sodium Channels
  • SCNN1A protein, human
Topics
  • Epithelial Sodium Channels (genetics)
  • Essential Hypertension
  • Humans
  • Hypertension (genetics)
  • Polymorphism, Single Nucleotide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: